Transdermal rotigotine effective adjunct in Parkinson's disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1588, 2007-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Rotigotine Transdermal Patch in Parkinson's Disease†

By Sanford Mark Scott Lesley J.

Drugs & Aging, Vol. 28, Iss. 12, 2011-12 ,pp. : 1015-1017

Adis International

Access to resources Recommend Favorite

Rotigotine Transdermal Patch: A Review of its Use in the Treatment of Parkinson's Disease

By Sanford Mark Scott Lesley J.

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite

Rotigotine Transdermal Patch: A Review of its Use in the Management of Parkinson's Disease

By Baldwin Claudine M. Keating Gillian M.

CNS Drugs, Vol. 21, Iss. 12, 2007-01 ,pp. : 1039-1055

Adis International

Access to resources Recommend Favorite

Istradefylline effective adjunct therapy for Parkinson's disease

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Rotigotine reliable in Parkinson's disease

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite